Cannabidiol (CBD) Segmentation
The market is segmented by source into hemp, and marijuana, out of which, the hemp segment is anticipated to hold a significant share in the market during the forecast period owing to its higher plantation across the globe. On the basis of application, the market is segmented into medicinal, research, and personal, out of which the research segment is projected to witness highest CAGR over the forecast period on the back of growing research on effects of cannabis on human nervous system and its other uses. Use of CBD oil as a medicine has not gained popularity among the masses yet, but this segment is expected to gain prominence in the upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Source |
|
|
By Application |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cannabidiol Market in 2025 is estimated at USD 10.43 billion.
The global market size was valued at over USD 9.27 billion in 2024 and is expected to expand at a CAGR of around 15.7%, surpassing USD 61.72 billion revenue by 2037.
North America is poised to hit USD 21.6 billion by 2037, driven by health-awareness, the acceptance of cannabis-based products, and research on cannabinoids.
The major players in the market include Medical Marijuana Inc., Cannoid, LLC, Isodiol International Inc., ENDOCA, Folium Biosciences, Aurora Cannabis Inc., Elixinol Global, CV Sciences, Medterra CBD, PharmaHemp.
